NCT02151448 2020-07-20
αDC1 Vaccine + Chemokine Modulatory Regimen (CKM) as Adjuvant Treatment of Peritoneal Surface Malignancies
University of Pittsburgh
Phase 1/2 Completed
Clinical Trials
1 trialsPhase 1/2 × Peritoneal Neoplasms × AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase × Clear all